LIDCX
Price
$9.52
Change
+$0.04 (+0.42%)
Updated
Aug 8 closing price
Net Assets
460.5M
TROZX
Price
$21.99
Change
+$0.09 (+0.41%)
Updated
Aug 8 closing price
Net Assets
16.08B
Interact to see
Advertisement

LIDCX vs TROZX

Header iconLIDCX vs TROZX Comparison
Open Charts LIDCX vs TROZXBanner chart's image
Lord Abbett International Value C
Price$9.52
Change+$0.04 (+0.42%)
VolumeN/A
Net Assets460.5M
T. Rowe Price International Value Eq Z
Price$21.99
Change+$0.09 (+0.41%)
VolumeN/A
Net Assets16.08B
LIDCX vs TROZX Comparison Chart in %
Loading...
View a ticker or compare two or three
Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
TROZX has more cash in the bank: 16.1B vs. LIDCX (460M). TROZX pays higher dividends than LIDCX: TROZX (2.86) vs LIDCX (2.23). LIDCX was incepted earlier than TROZX: LIDCX (17 years) vs TROZX (5 years). LIDCX (1.74) is less costly to investors than TROZX (0.66). LIDCX is a more actively managed with annual turnover of: 54.00 vs. TROZX (15.90). TROZX has a lower initial minimum investment than LIDCX: TROZX (0) vs LIDCX (1500). TROZX annual gain was more profitable for investors over the last year : 31.30 vs. LIDCX (24.57). TROZX return over 5 years is better than : 106.73 vs. LIDCX (65.56).
LIDCXTROZXLIDCX / TROZX
Total Expense Ratio1.740.00-
Annual Report Gross Expense Ratio1.740.66264%
Fund Existence17 years5 years-
Gain YTD23.88430.58278%
Front LoadN/AN/A-
Min. Initial Investment15000-
Min. Initial Investment IRAN/AN/A-
Net Assets460M16.1B3%
Annual Yield % from dividends2.232.8678%
Returns for 1 year24.5731.3079%
Returns for 3 years52.4379.3166%
Returns for 5 years65.56106.7361%
Returns for 10 years50.87N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DEW58.530.30
+0.51%
WisdomTree Global High Dividend ETF
XTJA30.070.14
+0.47%
Innovator US Equity Acclrtd Pls ETF Jan
EVYM47.920.05
+0.10%
Eaton Vance High Income Municipal ETF
ICVT91.87-0.21
-0.23%
iShares Convertible Bond ETF
HQL13.20-0.06
-0.45%
abrdn Life Sciences Investors